Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2020-03-19 2020-01-30
Drug Identification Number 02412209 02412209
Brand name TEVA-TOLTERODINE LA TEVA-TOLTERODINE LA
Common or Proper name TOLTERODINE 4MG ER CAPS TOLTERODINE 4MG ER CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TOLTERODINE TARTRATE TOLTERODINE TARTRATE
Strength(s) 4MG 4MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100's and 30's 100
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-29 2020-01-29
Estimated end date 2020-03-31 2020-02-29
Actual end date 2020-03-18
Shortage status Resolved Actual shortage
Company comments
Health Canada comments